Literature DB >> 11106423

Involvement of calcium-independent phospholipase A2 in uterine stromal cell phospholipid remodelling.

H Birbes1, S Drevet, J F Pageaux, M Lagarde, C Laugier.   

Abstract

The role of Ca2+-independent phospholipase A2 (iPLA2) in arachidonic (AA) and docosahexaenoic (DHA) acid incorporation and phospholipid remodelling in rat uterine stromal cells (UIII cells) was studied. Incorporation of AA and DHA into UIII cell phospholipids was Ca2+-independent. Bromoenollactone (BEL), a potent inhibitor of iPLA2, reduced lysophosphatidylcholine level and AA incorporation into phospholipids by approximately 20%. DHA incorporation was not affected by BEL, indicating that the pathways for AA and DHA incorporation are partially different. In control cells, the transfer of AA occurred mainly from diacyl-glycerophosphocholine (GroPCho) to alkenylacyl-glycerophosphoethanolamine (GroPEtn) and to a lesser extent from diacyl-GroPCho to diacyl-GroPEtn. [3H]DHA was redistributed from diacyl-GroPCho and alkylacyl-GroPEtn to alkenylacyl-GroPEtn. BEL treatment inhibited completely the redistributrion of AA within diacyl-GroPCho and diacyl -GroPEtn and reduced the [3H]DHA content of diacyl-GroPEtn, indicating that a BEL-sensitive iPLA2 controls the redistribution of polyunsaturated fatty acids to diacyl-GroPEtn. In contrast the redistribution of radioactive AA and DHA to alkenylacyl-GroPEtn was almost insensitive to BEL. The analysis of substrate specificity and BEL sensitivity of iPLA2 activity indicates that UIII cells exhibit at least two isoforms of iPLA2, one of which is BEL-sensitive and quite selective of diacyl species, and another one that is insensitive to BEL and selective for alkenylacyl-GroPEtn. Taken together, these results suggest that several iPLA2 participate independently in the remodelling of UIII cell phospholipids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106423     DOI: 10.1046/j.1432-1327.2000.01814.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.

Authors:  Daren Stephens; Efrosini Barbayianni; Violetta Constantinou-Kokotou; Anna Peristeraki; David A Six; Jennifer Cooper; Richard Harkewicz; Raymond A Deems; Edward A Dennis; George Kokotos
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

2.  Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.

Authors:  George Kokotos; Yuan-Hao Hsu; John E Burke; Constantinos Baskakis; Christoforos G Kokotos; Victoria Magrioti; Edward A Dennis
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

3.  Roles of various phospholipases A2 in providing lysophospholipid acceptors for fatty acid phospholipid incorporation and remodelling.

Authors:  Jesús Balsinde
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

4.  New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2.

Authors:  Victoria Magrioti; Aikaterini Nikolaou; Annetta Smyrniotou; Ishita Shah; Violetta Constantinou-Kokotou; Edward A Dennis; George Kokotos
Journal:  Bioorg Med Chem       Date:  2013-07-16       Impact factor: 3.641

Review 5.  Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.

Authors:  Atsushi Yamashita; Yasuhiro Hayashi; Naoki Matsumoto; Yoko Nemoto-Sasaki; Takanori Koizumi; Yusuke Inagaki; Saori Oka; Takashi Tanikawa; Takayuki Sugiura
Journal:  Biology (Basel)       Date:  2017-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.